← Back to headlines
Novo Partners with Vivtex for Obesity Drug Pipeline
Novo Nordisk has announced a partnership with biotech company Vivtex to enhance and expand its pipeline of obesity drugs.
25 Feb, 14:18 — 25 Feb, 14:18
Sources
Showing 1 of 1 sources



